PP#161 - Pre-clinical evaluation of 225Ac-DOTATOC pharmacokinetics, dosimetry, and toxicity to enable Phase-1 clinical trial in patients with neuroendocrine tumors von Norenberg, J., Anderson, T., Hesterman, J., Orcutt, K., Nysus, M., Kusewitt, D., Fair, J., Soares, H., John, K., Rixe, O.

Volltext

Pre-clinical evaluation of 225Ac-DOTATOC pharmacokinetics, dosimetry, and toxicity to enable Phase-1 clinical trial in patients with neuroendocrine tumors von Norenberg, J., Anderson, T., Hesterman, J., Orcutt, K., Nysus, M., Kusewitt, D., Fair, J., Soares, H., John, K., Rixe, O.

Volltext

RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia von Matthijssens, F, Sharma, ND, Nysus, M, Nickl, CK, Kang, H, Perez, DR, Lintermans, B, Van Loocke, W, Roels, J, Peirs, S, Demoen, L, Pieters, T, Reunes, L, Lammens, T, De Moerloose, B, Van Nieuwerburgh, F, Deforce, DL, Cheung, LC, Kotecha, RS, Risseeuw, MDP, Van Calenbergh, S, Takarada, T, Yoneda, Y, Van Delft, FW, Lock, RB, Merkley, SD, Chigaev, A, Sklar, LA, Mullighan, CG, Loh, ML, Winter, SS, Hunger, SP, Goossens, S, Castillo, EF, Ornatowski, W, Van Vlierberghe, P, Matlawska-Wasowska, K

Volltext bestellen